Capital Fund Management S.A. Trims Holdings in INC Research Holdings, Inc. (INCR)
Capital Fund Management S.A. lowered its position in INC Research Holdings, Inc. (NASDAQ:INCR) by 40.9% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,951 shares of the company’s stock after selling 11,056 shares during the quarter. Capital Fund Management S.A.’s holdings in INC Research Holdings were worth $933,000 as of its most recent SEC filing.
Other hedge funds have also recently made changes to their positions in the company. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of INC Research Holdings by 14.8% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,765 shares of the company’s stock worth $103,000 after acquiring an additional 228 shares during the period. Pacad Investment Ltd. acquired a new position in shares of INC Research Holdings in the 2nd quarter worth approximately $123,000. Victory Capital Management Inc. raised its holdings in shares of INC Research Holdings by 17.6% in the 2nd quarter. Victory Capital Management Inc. now owns 2,377 shares of the company’s stock worth $139,000 after buying an additional 356 shares in the last quarter. Invictus RG acquired a new position in shares of INC Research Holdings in the 1st quarter worth approximately $115,000. Finally, Foresters Investment Management Company Inc. acquired a new position in shares of INC Research Holdings in the 1st quarter worth approximately $128,000. Institutional investors own 98.97% of the company’s stock.
In related news, CAO Christopher L. Gaenzle sold 6,873 shares of the business’s stock in a transaction that occurred on Friday, June 30th. The stock was sold at an average price of $58.32, for a total value of $400,833.36. Following the completion of the sale, the chief accounting officer now directly owns 47,450 shares in the company, valued at $2,767,284. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Alistair Macdonald sold 10,555 shares of the business’s stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $58.38, for a total value of $616,200.90. Following the completion of the sale, the chief executive officer now owns 83,935 shares of the company’s stock, valued at $4,900,125.30. The disclosure for this sale can be found here. Over the last quarter, insiders sold 199,016 shares of company stock valued at $11,655,556. 0.24% of the stock is currently owned by corporate insiders.
TRADEMARK VIOLATION NOTICE: This article was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another website, it was stolen and reposted in violation of United States & international copyright legislation. The correct version of this article can be read at https://www.thecerbatgem.com/2017/09/16/capital-fund-management-s-a-trims-holdings-in-inc-research-holdings-inc-incr.html.
INC Research Holdings, Inc. (NASDAQ:INCR) opened at 54.85 on Friday. The stock has a 50 day moving average price of $56.06 and a 200-day moving average price of $52.41. The firm has a market capitalization of $2.97 billion, a PE ratio of 33.61 and a beta of 1.41. INC Research Holdings, Inc. has a one year low of $40.65 and a one year high of $61.10.
INC Research Holdings (NASDAQ:INCR) last issued its quarterly earnings results on Thursday, July 27th. The company reported $0.64 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.64. The business had revenue of $258.10 million during the quarter, compared to analysts’ expectations of $256.76 million. INC Research Holdings had a return on equity of 40.69% and a net margin of 5.69%. The firm’s revenue for the quarter was down .3% compared to the same quarter last year. During the same period in the previous year, the company posted $0.61 earnings per share. On average, equities analysts forecast that INC Research Holdings, Inc. will post $2.62 earnings per share for the current year.
A number of equities analysts have recently issued reports on the company. Goldman Sachs Group, Inc. (The) reissued a “buy” rating and issued a $65.00 target price on shares of INC Research Holdings in a report on Monday, August 7th. William Blair cut INC Research Holdings from an “outperform” rating to a “market perform” rating in a report on Tuesday, June 20th. SunTrust Banks, Inc. raised INC Research Holdings from a “hold” rating to a “buy” rating and increased their target price for the stock from $48.00 to $67.00 in a report on Wednesday, May 31st. Jefferies Group LLC cut INC Research Holdings from a “buy” rating to a “hold” rating and increased their target price for the stock from $62.00 to $64.00 in a report on Thursday, June 29th. Finally, KeyCorp raised INC Research Holdings from a “sector weight” rating to an “overweight” rating and set a $68.00 target price for the company in a report on Monday, June 5th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and five have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $63.79.
INC Research Holdings Profile
INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.
Want to see what other hedge funds are holding INCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for INC Research Holdings, Inc. (NASDAQ:INCR).
Receive News & Stock Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related stocks with our FREE daily email newsletter.